Search results for "Primary"

showing 10 items of 2384 documents

Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment.

2018

RESUMEN Introducción: la colangitis biliar primaria (CBP) es una enfermedad rara, de la que existe información limitada en España sobre su epidemiología y manejo en la práctica clínica habitual. Objetivos: conocer la epidemiología, flujo del paciente, diagnóstico, seguimiento y tratamiento de la CBP en España. Métodos: revisión de la literatura y estudio siguiendo la metodología Delphi con participación de 28 especialistas en dos rondas de consulta y un taller de validación de resultados presencial. Resultados: existen, aproximadamente, 9.400 pacientes con CBP en España, con una incidencia anual de entre 0,51 y 3,86 casos/100.000 habitantes, aunque el margen de error se presupone alto dada …

medicine.medical_specialtyDelphi TechniqueEpidemiologyBiopsia hepaticaPopulationLineaAnnual incidence03 medical and health sciences0302 clinical medicineColangitis biliar primariaDiagnosisEpidemiologyEpidemiologíaTratamientoMedicineHumansIn patienteducationGynecologyeducation.field_of_studybusiness.industryLiver Cirrhosis BiliaryDiagnósticoPrimary biliary cholangitisGastroenterologyGeneral MedicineResponse to treatmentPatient flowTreatmentSpain030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessFollow-Up Studies
researchProduct

Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration

2018

Abstract Fibrates are drugs that reduce triglycerides, elevate high-density lipoproteins, as well as decrease small, dense LDL particles. The results of a study have recently been published by the Cochrane Collaboration on fibrates efficacy and safety in the primary prevention of cardiovascular disease. This study includes a systematic review and a meta-analysis of 6 studies (16,135 patients) that evaluated the clinical benefits of fibrates compared to placebo use or other lipid-lowering drugs. This review showed evidence of a protective effect of the fibrates compared with placebo as regards a reduction 16% of a compound objective of death due to cardiovascular disease, non-fatal myocardia…

medicine.medical_specialtyDiseasePlacebochemistry.chemical_compoundInternal medicinePrimary preventionmedicineHumansMyocardial infarctionHypolipidemic AgentsGeneral Environmental ScienceCreatinineCochrane collaborationbusiness.industryFibric AcidsGeneral EngineeringDiabetic retinopathymedicine.diseaseLipidsPrimary PreventionTotal mortalitychemistryCardiovascular DiseasesCreatinineGeneral Earth and Planetary SciencesDrug Therapy CombinationHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessClínica e Investigación en Arteriosclerosis (English Edition)
researchProduct

Review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes mellitus patients and their importance in primary care.

2019

Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes mellitus (T2DM). Furthermore, CKD confers a considerable increase in the risk of cardiovascular (CV) morbidity and mortality. In line with the need to improve knowledge in this field, this article aims to describe the renal endpoints used in the different cardiovascular outcome trials (CVOTs). The objective is to better know the renal variables used in the different CVOTs in order to optimize the implementation of advances in the prevention of progressive diabetic kidney disease in patients with T2DM in clinical practice.

medicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismDiseasePrimary careType 2 diabetesurologic and male genital diseasesGlobal HealthDiabetic nephropathy03 medical and health sciences0302 clinical medicineRisk FactorsDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsDiabetic Nephropathies030212 general & internal medicineIntensive care medicineNutrition and DieteticsPrimary Health Carebusiness.industryType 2 Diabetes Mellitusmedicine.diseaseClinical trialSurvival RateDiabetes Mellitus Type 2Cardiovascular DiseasesMorbidityFamily PracticebusinessKidney diseasePrimary care diabetes
researchProduct

Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction

2008

Endothelial dysfunction (ED) in the setting of cardiovascular risk factors such as hypercholesterolemia, hypertension, diabetes mellitus, chronic smoking as well as in patients with heart failure has been shown to be at least in part dependent on the production of reactive oxygen species (ROS) such as superoxide and the subsequent decrease in vascular bioavailability of nitric oxide (NO). Methods to quantify endothelial dysfunction include forearm plethysmography, flow-dependent dilation of the brachial artery, finger-pulse plethysmography, pulse curve analysis, and quantitative coronary angiography after intracoronary administration of the endothelium-dependent vasodilator acetylcholine. S…

medicine.medical_specialtyEndotheliumPathogenesisRisk FactorsDiabetes mellitusInternal medicinemedicineAnimalsHumansEndothelial dysfunctionClinical Trials as Topicbusiness.industrynutritional and metabolic diseasesGeneral MedicinePrognosismedicine.diseaseAscorbic acidPathophysiologyPrimary PreventionEndothelial stem cellOxidative StressEndocrinologymedicine.anatomical_structureCardiovascular DiseasesHeart failureCardiologyEndothelium VascularReactive Oxygen SpeciesbusinessBiomarkersAnnals of Medicine
researchProduct

Chronic non-cancer pain in primary care: an Italian cross-sectional study

2021

Chronic non-cancer pain is a complex health condition that affects more than a quarter of the Italian population who mainly refers to general practitioners and primary care for their treatment. There are little information on the epidemiological and clinical characteristics and types of treatments for these patients who suffer from chronic pain. The aim of the study was to provide epidemiological and clinical information about patients with chronic non-cancer pain who refers to GPs for their treatment. An observational, multicentre, cross-sectional study was carried out using retrospectively reviewed clinical records from 29 GPs. Some pharmacoeconomic aspects were also investigated. A total…

medicine.medical_specialtyEpidemiologyGeneral Practitionerbusiness.industryCross-sectional studyNon cancerChronic Pain; Epidemiology; General Population; General Practitioner; Italy; Pain Management; Primary careChronic painNursingPrimary carePrimary caremedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheItalian populationAcetaminophenItalyInternal medicineEpidemiologyGeneral PopulationmedicinePain ManagementObservational studyChronic Painbusinessmedicine.drugSigna Vitae
researchProduct

Corrigendum to “Leisure-time physical activity and metabolic syndrome plus depressive symptoms in the FIN-D2D survey” [Preventive Medicine 51 (2010) …

2011

a Department of Health Sciences, University of Jyvaskyla, PL 35, FI-40014 Jyvaskyla, Finland b Department of Physical and Rehabilitation Medicine, Central Finland Health Care District, Keskussairaalantie 19, FI-40620 Jyvaskyla, Finland c Unit of General Practice, Central Finland Health Care District, Keskussairaalantie 19, FI-40620 Jyvaskyla, Finland d ORTON, Rehabilitation Unit, PO Box 29, FI-00281, Helsinki, Finland e Department of Psychiatry, University of Eastern Finland and Kuopio University Hospital, FI-70210 Kuopio, Finland f National Institute for Health and Welfare, PO Box 30, FI-00271, Helsinki, Finland g Department of Primary Healthcare, University of Eastern Finland and Unit of …

medicine.medical_specialtyEpidemiologybusiness.industryLeisure timePublic Health Environmental and Occupational HealthMedical schoolPrimary health carePhysical activityRehabilitation unitUniversity hospitalFamily medicineHealth careMedicinebusinessPsychiatryDepressive symptomsPreventive Medicine
researchProduct

NAM Therapy-Evidence-Based Results

2020

Many orthodontists working on patients with cleft lip and palate (CLP) have shown great enthusiasm for presurgical infant orthopedics (PSIO) to improve surgical outcomes with minimal intervention. Even though every clinician aims to use the best treatment modality for their patients, PSIO effects can be confounded by surgical type and timing of the primary repair, as is discussed in many studies. In such cases, one should be cautious when evaluating the particular outcomes for patients with CLP since it is difficult to differentiate the sole effect of an individual surgical or orthodontic intervention. As with any treatment methodology, nasoalveolar molding (NAM) has both benefits and limi…

medicine.medical_specialtyEvidence-based practiceinfant orthopedicmedicine.medical_treatmentCleft Lipmidfacial growthNoseBurden of care03 medical and health sciencesPrimary repair0302 clinical medicineIntervention (counseling)medicineDeformityMaxillaHumansOrthopedic Procedures030223 otorhinolaryngologyIntensive care medicineMaxillary growthReduction (orthopedic surgery)business.industryInfant orthopedicsInfant030206 dentistryPlastic Surgery ProceduresCleft PalateOtorhinolaryngologyfacial growthOral Surgerymedicine.symptombusinessnonsyndromic clefting
researchProduct

Macular edema: Miscellaneous.

2010

International audience; Abstract. This article provides the reader with practical information to be applied to the various remaining causes of macular edema. Some macular edemas linked to ocular diseases like radiotherapy after ocular melanomas remained of poor functional prognosis due to the primary disease. On the contrary, macular edemas occurring after retinal detachment or after some systemic or local treatment use are often temporary. Macular edema associated with epiretinal membranes or vitreomacular traction is the main cause of poor functional recovery. However, the delay to observe a significant improvement of vision after surgery should be long, as usually observed in tractional …

medicine.medical_specialtyEye Diseasesgenetic structuresVitreomacular tractionPrimary diseaseTreatment useMacular EdemaHemangiomaOphthalmologyProstaglandins SyntheticmedicineHumans[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansMacular edemaRadiotherapymedicine.diagnostic_testbusiness.industryRetinal detachmentGeneral MedicineFunctional recoverymedicine.diseaseFluorescein angiographyeye diseasesOphthalmology[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory Organssense organsOphthalmic Solutionsbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020

2020

The recommendations of the semFYC's Program for Preventive Activities and Health Promotion (PAPPS) for the prevention of cardiovascular diseases (CVD) are presented. The following sections are included: Epidemiological review, where the current morbidity and mortality of CVD in Spain and its evolution as well as the main risk factors are described; Cardiovascular (CV) risk tables and recommendations for the calculation of CV risk; Main risk factors such as arterial hypertension, dyslipidemia and diabetes mellitus, describing the method for their diagnosis, therapeutic objectives and recommendations for lifestyle measures and pharmacological treatment; Indications for antiplatelet therapy, a…

medicine.medical_specialtyFamily medicineMedicina:Health Care::Environment and Public Health::Public Health::Epidemiologic Factors::Causality::Risk Factors [Medical Subject Headings]030204 cardiovascular system & hematologyPharmacological treatment:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Diseases::Cardiovascular Diseases::Vascular Diseases::Hypertension [Medical Subject Headings]03 medical and health sciences0302 clinical medicineDiabetes mellitusDiabetes mellitusEpidemiologymedicine030212 general & internal medicineIntensive care medicine:Diseases::Cardiovascular Diseases [Medical Subject Headings]lcsh:R5-920:Diseases::Endocrine System Diseases::Diabetes Mellitus [Medical Subject Headings]business.industryMedicina de familia:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Psychology Social::Life Style [Medical Subject Headings]Atrial fibrillationGeneral MedicineAtención primariamedicine.diseasePrimary careCardiovasculardiseasesHealth promotionCardiovascular diseases:Health Care::Health Care Facilities Manpower and Services::Health Promotion [Medical Subject Headings]Preventive activitiesEnfermedades cardiovasculareslcsh:Medicine (General)Family PracticebusinessDyslipidemia
researchProduct

Cluster headache in relation to different age groups

2019

Cluster headache (CH) has always been considered a type of primary headache affecting predominantly male subjects in early and medium adulthood. However, recent studies carried out in large case series of patients with CH show that not infrequently it may set in also after age 50; by contrast, onset before adolescence is very rare. Additionally, when onset occurs before age 14 or from the sixth decade of life onward, male predominance decreases to the point that in chronic forms CH predominantly affects the female sex. This particular pattern of the gender ratio in relation to onset in different age groups suggests that hormonal factors may actually play a role in the genesis of CH. In part…

medicine.medical_specialtyFuture studiesNeurologyEpidemiologymedicine.drug_classPhysiologyCluster HeadacheDermatology03 medical and health sciences0302 clinical medicinePrimary headacheAge groupsEpidemiologyPrevalencemedicineHumans030212 general & internal medicineAge of Onsetbusiness.industryCluster headacheAge FactorsAge at onsetGeneral Medicinemedicine.diseasePsychiatry and Mental healthEstrogenChronic DiseaseDisease ProgressionNeurology (clinical)businessBiomarkers030217 neurology & neurosurgerySex ratioNeurological Sciences
researchProduct